To investigate the antitumor effects of B7-H3.CAR-T cells in vivo, we implemented a metastatic NSCLC model by infusing FFluc-expressing A549 tumor cells via tail vein injection (i.v.)in NSG mice, and treated them with CAR-T cells (Fig. 2a). Here, CD276 is linked to neoplasm.